Last reviewed: June 17, 2026

Last updated: June 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide belongs to a class of medications called GLP-1 receptor agonists, originally developed to manage type 2 diabetes. Clinical research shows that patients using semaglutide for weight management lose an average of 10-15% of their body weight over 68 weeks. PlexusDx provides access to this medication through licensed compounding pharmacies, serving all 50 states with transparent pricing and no membership requirements.

Understanding How Semaglutide Works for Weight Loss

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a hormone your body naturally produces in the intestines. This hormone signals your brain that you are full, slowing gastric emptying and reducing hunger signals. By activating GLP-1 receptors in the brain and digestive system, semaglutide creates a sustained feeling of satiety, which leads to reduced calorie intake without the willpower struggle many face with traditional dieting.

The medication also improves insulin sensitivity and helps regulate blood sugar levels, which can reduce cravings for high-carbohydrate foods. Many patients report that food becomes less psychologically rewarding while on semaglutide, meaning they no longer experience the intense desire to eat that previously drove their weight gain. This dual mechanism—physical fullness plus reduced food motivation—explains why semaglutide produces weight loss in the majority of users.

Clinical Evidence: Weight Loss Results with Semaglutide

The STEP trials, which enrolled over 4,500 participants, demonstrated that semaglutide produced a mean weight loss of 9.2-12.4 kg (20-27 lbs) compared to placebo over 68 weeks when combined with lifestyle modification. Participants taking the highest dose experienced weight reductions of 15-18% of their baseline body weight, with many achieving and maintaining these results beyond the trial period. These results represent one of the most significant weight-loss outcomes ever recorded for a pharmaceutical intervention.

Real-world data from clinical practices mirrors these trial results, with patients reporting sustained weight loss beyond the first year. The weight loss typically plateaus after 6-9 months, at which point many patients maintain their results with continued medication use. Discontinuing semaglutide often results in gradual weight regain, suggesting that ongoing therapy may be necessary for long-term weight management in individuals with genetic predisposition to obesity.

Semaglutide Dosing and Your Price at PlexusDx

Semaglutide therapy begins at a low dose—typically 0.25 mg weekly—and increases gradually every 4 weeks to improve tolerability and minimize side effects. Most patients reach their therapeutic dose between 1.0 and 2.4 mg weekly, though optimal dosing varies based on individual response and tolerance. Your dose may need to go up. Your price won't. PlexusDx charges a flat monthly rate of $149-$189 depending on your commitment tier, regardless of your current dose level.

PlexusDx offers semaglutide injections compounded at licensed 503A pharmacies, ensuring pharmaceutical quality and safety oversight. The medication is available in multiple concentration options to accommodate dose escalation without changing your monthly cost. HSA and FSA funds are eligible for PlexusDx semaglutide, making it accessible even without insurance coverage.

Side Effects and What to Expect During Treatment

Common side effects include nausea, vomiting, diarrhea, and constipation, particularly during dose escalation phases. Most gastrointestinal effects diminish over 2-4 weeks as your body adjusts to the medication. Starting at the lowest dose and increasing gradually allows your system to adapt, reducing the likelihood of severe nausea that causes some patients to discontinue therapy.

Rare but serious side effects include pancreatitis and changes in thyroid function, which is why baseline and periodic medical evaluation is important. Patients with a personal or family history of thyroid cancer should not use semaglutide. PlexusDx treatment protocols include health screening before starting therapy and ongoing clinical oversight to monitor for adverse effects and ensure safe, effective weight loss.

Personalized Semaglutide Therapy with Genetic Testing

Not everyone responds equally to semaglutide—genetic variation in GLP-1 receptor expression and appetite-regulation pathways influences how effectively the medication works for you. The PlexusDx Precision Peptide Genetic Test analyzes 150+ genetic insights across 49 peptides and 14 biological pathways to predict your likely response to semaglutide and other GLP-1 therapies. Key variants like GLP1R rs6923761 and GIPR rs1800437 directly influence how your body responds to these medications.

The Precision Peptide Genetic Test ($99 add-on after your first month of treatment) helps PlexusDx specialists identify whether semaglutide alone is optimal for you, or whether a combination therapy might produce better results. This personalized approach removes guesswork from weight-loss medication selection, increasing your chances of achieving your goals while minimizing side effects and cost.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I see weight loss on semaglutide?

Most patients notice appetite reduction within the first week, with measurable weight loss appearing within 2-4 weeks. Significant weight loss typically becomes apparent after 8-12 weeks as your dose increases and your body adjusts. Individual timelines vary based on baseline weight, metabolism, and adherence to lifestyle changes alongside medication.

Is compounded semaglutide as effective as brand-name Ozempic?

Semaglutide from licensed 503A compounding pharmacies contains the identical active ingredient as brand-name formulations and produces equivalent weight-loss results. PlexusDx compounds semaglutide at licensed pharmacies subject to strict quality and sterility standards, ensuring pharmaceutical-grade safety and efficacy at a fraction of brand-name cost.

Can I use HSA or FSA funds to pay for PlexusDx semaglutide?

Yes, semaglutide from PlexusDx is eligible for both Health Savings Accounts and Flexible Spending Accounts, making it more affordable than paying out-of-pocket. No insurance is required to access PlexusDx treatment, and there are no membership fees—just transparent monthly pricing starting at $149.

What happens if I stop taking semaglutide?

Weight regain is common after discontinuing semaglutide, as your body's appetite-regulation hormones return to pre-treatment levels. Many patients regain 25-50% of lost weight within 6-12 months after stopping, which is why ongoing therapy is typically needed for sustained weight management in people with obesity-related genetic predispositions.

How does the Precision Peptide Genetic Test help with semaglutide treatment?

The test identifies your genetic variants in GLP-1 receptors, appetite-control pathways, and metabolic genes to predict semaglutide effectiveness and optimal dosing. This personalization helps PlexusDx specialists determine whether oral or injectable semaglutide suits you best, or whether combining it with tirzepatide might improve your results.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves